MED vs TLRY · rev $152.4M vs rev $915.5M
MEDIFAST INC (MED) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
MEDIFAST INC (MED) is a personal services company listed on NYSE.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MED revenue for 2026-06-30 was $152.4M. Net income was -$5.2M. MED currently screens at market cap $125.3M.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
MED currently screens at market cap $125.3M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the MED and TLRY stock pages for the full models.
Not investment advice.